Practical synthesis of L-erythro- and L-threo-4-fluoroglutamic acids using aminoacylase

Tetrahedron Asymmetry

Volumn 7, Issue 12, 1996, Pages 3545-3551

  Kokuryo, Yoshitsugu ^a   Nakatani, Takuji ^a   Kobayashi, Kobee ^a   Tamura, Yoshinori ^a   Kawada, Kenji ^a   Ohtani, Mitsuaki ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACYLASE; GLUTAMIC ACID DERIVATIVE;

ARTICLE; CRYSTALLIZATION; DRUG SYNTHESIS; ENANTIOMER; HYDROLYSIS; PRIORITY JOURNAL; PURIFICATION; STEREOCHEMISTRY;

EID: 0030561462     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(96)00462-4     Document Type: Article

References (38)

1. 1. (a) Kollonitsch, J. In Biomedical Aspects of Fluorine Chemistry; Filler, R., Kobayashi, Y., Eds.; Kodansha: Tokyo, 1982, pp. 93-122.
2. (b) Tsushima, T.; Kawada, K. In Fluorine Chemistry in Pharmaceutical Sciences, Basic and Experimental; Kobayashi, Y., Kumadaki, I., Taguchi, T., Eds.; Hirokawa Publishing: Tokyo, 1993, pp. 55-72 (in Japanese),
3. (c) Symposium on Fluoro-Amino Acids and Peptides in Medicinal Chemistry; 210th ACS Meeting, Chicago, August, 1995.
4. 2. (a) Tsushima, T.; Kawada, K.; Shiratori, O.; Uchida, N. Heterocycles 1985, 23, 45.
5. (b) Tsushima, T.; Kawada, K.; Ishihara, S.; Uchida, N.; Shiratori, O; Higaki, J.; Hirata, M. Tetrahedron 1988, 44, 5375.
6. 3. For a recent review on fluorine chemistry, see: (a) Chemistry of Organic Fluorine Compounds II, A Critical Review, Hudlicky, M.; Pavlath, A. E. Eds.; American Chemical Society: Washington, D.C., 1995.
7. For recent results in this field, see: (b) Fluoroorganic Chemistry: Synthetic Challenges and Biomedical Rewards (Tetrahedron Symposium-in-Print); Tetrahedron 1996, 52, 1-330.
8. 4. (a) Galivan, J.; Ingless, J.; McGuire, J. J.; Nimec, Z; Coward, J. K. Proc. Natl. Acad. Sci., U.S.A. 1985, 82, 2598.
9. (b) Coward, J. K.; McGuire, J. J.; Galivan, J. In Selective Fluorination in Organic and Bioorganic Chemistry, Welch, J. T. Ed.; American Chemical Society: Washington, D.C., 1991; pp. 196-204.
10. 5. (a) Drug Stereochemistry, Wainer, I. W., Drayer, D. E. Eds.; Marcel Dekker: New York, 1988.
11. (b) Stinson, S. C. Chem. Eng. News 1995, October 9, 44.
12. (c) Cannarsa, M. J. Chem. Ind. (London) 1996, May 6, 374.
13. 6. For general reviews, see: (a) Bannwarth, B.; Labat, L.; Moride, Y.; Schaeverbeke, T. Drugs 1994, 47, 25.
14. (b) DeGraw, J. I.; Colwell, W. T.; Pipe, J. R.; Sirotnak, F. M.; Smith, R. L. Curr. Med. Chem. 1995, 2, 630.
15. 7. MTX analogue containing D-glutamic acid was reported to be a poor inhibitor of cell growth, see: (a) Cramer, S. M.; Schomagel, J. H.; Kalghatgi, K. K.; Bertino, J. R.; Horvath, C. Cancer Res. 1984, 44, 1843.
16. The in vitro activity of L-threo-3 has been reported recently, see: (b) Hart, B. P.; Haile, W. H.; Licato, N. J.; Bolanowska, W. E.; McGuire, J. J.; Coward, J. K. J. Med. Chem. 1996, 39, 56.
17. 8. (a) Hudlicky, M.; Merola J. S. Tetrahedron Lett. 1990, 31, 7403.
18. (b) Avent, A. G.; Bowler, A. N.; Doyle, P. M.; Marchand, C. M.; Young, D. W. Tetrahedron Lett. 1992, 33, 1509.
19. (c) Hudlicky, M. J. Fluorine Chem. 1993, 60, 193.
20. 9. (a) Unkeless, J. C.; Goldman, P. Mol. Pharmacol. 1971, 7, 293.
21. (b) Bory, S.; Dubois, J.; Gaudry, M.; Marquet, A.; Lacombe, L.; Weinstein, S. J. Chem. Soc., Perkin Trans. 1 1984, 475.
22. 10. Tolman V. J. Fluorine Chem. 1993, 60, 179, and references cited therein.
23. 11. Several kilograms of the adduct were purchased from Daikin Industries, Ltd., see: ref. 12.
24. 12. (a) Ohmori, A.; Takaki, S.; Kitahara, T. European Patent 136668 B1, 1987.
25. (b) Idem. Japan Patent Koho 1-50214, 1989.
26. 13. For a general review, see: (a) Williams, R. M. In Synthesis of Optically Active α-Amino Acids; Pergamon Press: New York, 1989; pp. 257-279.
27. For reviews on enzymatic preparation of fluorine-containing amino acids, see: (b) Matsumura, Y.; Urushihara, M. In Fluorine-containing Amino Acids: Synthesis and Properties; Kukhar, V. P., Soloshonok, V. A., Eds.; John Wiley & Sons: New York, 1995; pp 243-265.
28. (c) Miyazawa, T. Ibid. pp. 267-294.
29. 14. Burde, N. L.; Alekseeva, L. V.; Lundin, B. N. Zh. Obshch. Khim. 1968, 38, 439.
30. 15. (a) Gentzen, I.; Löffler, H.-G.; Schneider, F. Z. Naturforsch. 1980, 35c, 544.
31. (b) Chenault, H. K.; Dahmer, J.; Whitesides, G. M. J. Am. Chem. Soc. 1989, 111, 6354.
32. 16. Vidal-Cros, A.; Gaudry, M.; Marquet, A. J. Org. Chem. 1985, 50, 3163.
33. 17. Tolman, V.; Veres, K. Collect. Czech. Chem. Commun. 1967, 32, 4460.
34. 18. Rosen, H. Arch. Biochem. Biophys. 1957, 67, 10.
35. 19. Data of X-ray crystallographic analysis of both 1a and 1b can be obtained from Mr. H. Nakai of these Laboratories. The X-ray crystal structures of 1b and 1c were also reported by Hudlicky and Merola, see: ref. 8a.
36. 20. Tolman et al. reported that DL-threo-8·HCl was secured in high diastereomeric purity by recrystallization from acetone, see: Tolman, V.; Vlasakova, V.; Nemecek, J. Fluorine Chem. 1993, 60, 185.
37. 21. (a) Benson, J. R.; Hare, P. E. Proc. Natl. Acad. Sci., U.S.A. 1975, 72, 619.
38. (b) Gil-Av, E.; Tishbee, A.; Hare, P. E. J. Am. Chem. Soc. 1980, 102, 5115.